Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the whole-body biodistribution and tumour uptake of
89Zr-S095012 in participants with solid tumours treated by S095012 (PD-L1x4-1BB bispecific
antibody)